118 related articles for article (PubMed ID: 12660133)
1. [Economic assessment of adjuvant and palliative chemotherapy in colorectal cancer: a review].
Selke B; Lebrun T; Comte S
Bull Cancer; 2003 Feb; 90(2):143-9. PubMed ID: 12660133
[TBL] [Abstract][Full Text] [Related]
2. Cetuximab as First-line Treatment for Metastatic Colorectal Cancer: Caution With Interpretation of Cost-Effectiveness Results Toward Medical Decision Making.
Franken MD; Koopman M; van Oijen MG
Am J Clin Oncol; 2016 Apr; 39(2):214. PubMed ID: 26999056
[No Abstract] [Full Text] [Related]
3. [Chemotherapy for colorectal cancers].
Lièvre A; Mitry E
J Chir (Paris); 2003 Feb; 140(1):52-5. PubMed ID: 12709655
[TBL] [Abstract][Full Text] [Related]
4. [Advances in palliative and adjuvant chemotherapy of colon cancer].
Scheithauer W
Dtsch Med Wochenschr; 2004 Oct; 129(40):2118-21. PubMed ID: 15455304
[No Abstract] [Full Text] [Related]
5. An economic evaluation of Tomudex (raltitrexed) and 5-fluorouracil plus leucovorin in advanced colorectal cancer.
Groener MG; van Ineveld BM; Byttebier G; van Hout BA; Rutten FF
Anticancer Drugs; 1999 Mar; 10(3):283-8. PubMed ID: 10327033
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
7. [New chemotherapies for colorectal cancer treatment].
Louvet C
Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B51-6. PubMed ID: 11449145
[No Abstract] [Full Text] [Related]
8. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
Vaiani M; Trippoli S; Messori A
N Engl J Med; 2001 Jan; 344(4):305-6; author reply 306-7. PubMed ID: 11191660
[No Abstract] [Full Text] [Related]
9. Economic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancer.
Limat S; Bracco-Nolin CH; Legat-Fagnoni C; Chaigneau L; Stein U; Huchet B; Pivot X; Woronoff-Lemsi MC
Eur J Health Econ; 2006 Jun; 7(2):107-13. PubMed ID: 16474968
[TBL] [Abstract][Full Text] [Related]
10. Palliative treatment of patients with colorectal cancer.
Glimelius B
Scand J Surg; 2003; 92(1):74-83. PubMed ID: 12705554
[TBL] [Abstract][Full Text] [Related]
11. [Recent advance in chemotherapy for advanced colorectal cancer].
Aiba K
Gan To Kagaku Ryoho; 1996 Apr; 23(5):535-48. PubMed ID: 8678510
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy (5-fluorouracil and levamisole) in Dukes' B and C colorectal carcinoma. A cost-effectiveness analysis.
Norum J; Vonen B; Olsen JA; Revhaug A
Ann Oncol; 1997 Jan; 8(1):65-70. PubMed ID: 9093709
[TBL] [Abstract][Full Text] [Related]
13. Clinical and economic evaluation of first-line therapy with FOLFIRI or modified FOLFOX6 for metastatic colorectal cancer.
Ajima H; Ogata H; Fujita K; Miwa K; Sunakawa Y; Mizuno K; Ishida H; Yamashita K; Nakayama H; Kawara K; Takahashi H; Sasaki Y
Jpn J Clin Oncol; 2010 Jul; 40(7):634-8. PubMed ID: 20587616
[TBL] [Abstract][Full Text] [Related]
14. Current treatment options for advanced colorectal cancer.
Rougier P; Mitry E
Semin Oncol; 2000 Oct; 27(5 Suppl 10):30-3. PubMed ID: 11049030
[No Abstract] [Full Text] [Related]
15. A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancer.
Tumeh JW; Shenoy PJ; Moore SG; Kauh J; Flowers C
Am J Clin Oncol; 2009 Feb; 32(1):49-55. PubMed ID: 19194125
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy and colorectal cancer.
Sumpter K; Cunningham D
Semin Oncol; 2000 Oct; 27(5 Suppl 10):105-11. PubMed ID: 11049041
[No Abstract] [Full Text] [Related]
17. New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer.
Holen KD; Saltz LB
Lancet Oncol; 2001 May; 2(5):290-7. PubMed ID: 11905784
[TBL] [Abstract][Full Text] [Related]
18. [Drug clinics. How I treat. II. Therapeutic approaches to metastatic colorectal cancer].
Jerusalem G; Bours V; Fillet G
Rev Med Liege; 1998 Jun; 53(6):318-21. PubMed ID: 9713208
[TBL] [Abstract][Full Text] [Related]
19. [Adjuvant and palliative chemotherapy of colorectal cancer in Germany outside controlled trials].
Lamberti C; Lundin S; Bogdanow M; Gorschlüter M; Schmidt-Wolf IG; Sauerbruch T
Dtsch Med Wochenschr; 2006 Mar; 131(10):485-90. PubMed ID: 16511737
[TBL] [Abstract][Full Text] [Related]
20. Cost-minimization analysis of sequence changes between FOLFIRI and FOLFOX6 therapy for advanced colorectal cancer in Japan.
Miyazaki Y; Harada T; Akase T; Arakawa I; Inoue T
Clin Ther; 2009; 31 Pt 2():2433-41. PubMed ID: 20110051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
